FDA authorizes breath test to detect COVID-19
InspectIR COVID-19 Breathalyzer test can detect infections using only a breath sample and yield results in less than three minutes.
Food and Drug Administration
FDA clears second COVID booster
Millions of Americans 50 and older are now eligible to receive another booster shot, after the Food and Drug Administration authorized a new round of COVID-19 vaccines for those who want them. But there are questions about both the effectiveness and who will pay for the optional shots. Senior White House correspondent Weijia Jiang has the latest.
Sure, Brut deodorant sprays recalled nationwide due to benzene
Analysis finds "unexpected levels" of human carcinogen coming from propellant that sprays product out of the can.
Senate confirms Biden's pick to lead the FDA
Califf already served as FDA commissioner under the Obama administration.
Kids under 5 could get COVID vaccine by March
The White House said it will be ready to distribute Pfizer's vaccine for young children as soon as it has authorization, which could be as soon as March. Nancy Chen has the latest.
Pfizer asks FDA to allow COVID-19 vaccine for kids under 5
Children under the age of 5 are the only group not yet eligible for vaccination — but that could change soon.
Pfizer asks FDA to authorize vaccine for kids under 5
Pfizer has asked the FDA for emergency use authorization for its COVID-19 vaccine for children under 5, who have so far been ineligible for the vaccines. Nikki Battiste has the latest.
FDA gives full approval to Moderna's COVID vaccine
The FDA has given its full approval to Moderna's COVID vaccine for those who are 18 and older after reviewing additional data on its safety and effectiveness.
FDA gives full approval to Moderna's COVID-19 vaccine
The action means the FDA has completed the same rigorous review of Moderna's shot as other long-established vaccines.
Surgeon General on next steps against COVID
U.S. health care workers are required to be vaccinated against COVID-19 starting today under a federal mandate. This comes at a time when the country is experiencing the highest COVID-19 death rate in nearly a year. U.S. Surgeon General Dr. Vivek Murthy joins CBS News' Tanya Rivero and Nikki Battiste to discuss where the U.S. stands in combatting the virus, what we know about a new variant, and the importance of mental health.
Gottlieb doesn't expect vaccine for kids under 5 before late March
Dr. Scott Gottlieb, the former FDA commissioner, says the FDA and Pfizer are "looking very closely at the data that's accrued to see if they can make a decision around this."
Martin Shkreli ordered to return nearly $65 million
The so-called "Pharma Bro" is banned for life from participating in the pharmaceutical industry.
FDA OK's use of expired COVID tests in Florida
The FDA has extended the shelf life of up to 1 million expired COVID tests that were confirmed to have been stockpiled in a Florida warehouse last week, as the state deals with spike of cases.
FDA approves use of 1 million COVID tests that expired in Florida
Florida Governor Ron DeSantis said last week that the tests weren't distributed because of "low demand."
How antiviral pills could alter the pandemic
The FDA has authorized Pfizer's COVID-19 antiviral pill for emergency use. Dr. Jodie Guest joins Elaine Quijano on CBSN's "Red & Blue" with more on the state of the pandemic.
FDA approves booster shots for some kids
The Food and Drug Administration has authorized booster shots for kids ages 12 to 15 and immunocompromised children ages 5 to 11, in response to the Omicron variant, which is driving a surge of COVID-19 infections in the U.S. Dr. Dyan Hes, founder of Gramercy Pediatrics, joins CBSN to discuss the latest coronavirus headlines.
FDA expands access to Pfizer booster
The FDA authorized Pfizer's COVID-19 vaccine booster shot for children between the ages of 12 and 15. The CDC is expected to rule on the decision later this week. It comes as Omicron cases surge nationwide and millions of kids return to school following the holidays. CBS News' Wendy Gillette reports, and then Professor Jodie Guest, vice chair of the Department of Epidemiology at the Rollins School of Public Health at Emory University, joins CBSN to discuss the latest in the fight against COVID-19.
FDA authorizes booster for ages 12 to 15
As COVID-19 cases surge across the U.S. the FDA has authorized Pfizer booster shots for children ages 12 to 15. CBS News correspondent Meg Oliver reports on how schools are proceeding with their return to class. Then Dr. Rajeev Fernando, who specializes in global infectious diseases, joins CBSN to discuss the latest on the pandemic.
U.S. reaches record number new COVID cases
Nearly half a million new COVID-19 cases were recorded in the U.S. on Wednesday. That number from the CDC is the highest single-day tally since the start of the pandemic. CBS News correspondent Nancy Chen reports from New York City. Then Dr. Payal Patel, an infectious disease physician at the University of Michigan, joined CBSN's Elise Preston to discuss the latest on the nation's health crisis.
Why antigen tests may still work well for Omicron, despite "reduced sensitivity"
The FDA said some of the rapid at-home tests may have "reduced sensitivity" in detecting Omicron cases, but real-world results are still coming in.
U.S. COVID cases surge ahead of holidays
New cases of the Omicron variant are spreading rapidly in the U.S. ahead of the holidays. People are dealing with long lines at testing sites across the nation. At-home testing kits are also short in supply and pharmacies are limiting how many customers can buy. CBS News correspondent Nancy Chen reports from New York City. Then critical care physician Dr. Lakshmana Swamy joins CBSN's Debra Alfarone to discuss the latest on the pandemic.
FDA approves second COVID treatment pill
The FDA has authorized the second antiviral pill to treat COVID-19. CBS News' Michael George reports. Then Dr. Jeremy Faust, emergency physician at Brigham and Women's Hospital at Harvard Medical School, joins CBSN to break down how the drugs work. He also explains why he thinks the CDC should implement "circuit breakers," short-term restrictions on high-risk activities to help curb the spread of the Omicron variant.
Omicron spike collides with holiday travel surge
The FDA authorized the first pill to treat COVID-19. The milestone comes as U.S. cases, hospitalizations and deaths are all rising, with health officials warning of a possible tsunami of new Omicron cases that could overwhelm hospitals. Nancy Chen has the details.
FDA allows for abortion pills to be sent by mail
Prescribing will still be limited to doctors who complete special certification.
How companies like Puff Bar have avoided FDA regulation
The Food and Drug Administration banned flavored e-cigarettes, like Juul, citing their popularity among teens.
Interactive
These documents tell the story of the Cornell rape allegations
Hurricane Isaias threatens Gulf Coast with rain, flooding. See its path.
Fort Hood shooter's execution will be livestreamed, Pentagon says
Live
Trump promises not to resume Iran strikes before midterm elections
ICE agent shoots man in New York City's Marble Hill, authorities say
Exclusive
Obama throws support behind Pennsylvania Gov. Josh Shapiro's reelection bid
Guilfoyle associate says when she asked him for $100K, it was "quid pro quo"
El-Sayed and Rogers toss insults in Michigan Senate debate
